FDA Allows Florida to Import Cheaper Drugs From Canada

Follow Drugslib on

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

FRIDAY, Jan. 5, 2024 -- In what could prove to be a major turning point for the prescription drug market in the United States, the U.S. Food and Drug Administration has approved a Florida plan to import drugs from Canada.

U.S. residents can now buy directly from Canadian pharmacies out of their own pockets, but state Medicaid programs have not been allowed to purchase medications in bulk from Canada. On average, U.S. drug prices are more than double those found in Canada, according to a Rand Corp. analysis. Brand-name drugs are even more expensive, with U.S. prices nearly triple those of Canadian prices, the report adds.

Florida says it could save up to $150 million in the first year of the program by importing medicines that treat HIV, AIDS, diabetes, hepatitis C, mental health disorders, and other conditions, the state claimed in a lawsuit filed against the FDA regarding its proposed importation program.

FDA Commissioner Robert Califf, M.D., said in a statement issued Friday that his agency is "committed to working with states and Indian tribes" that want to develop similar importation programs. "These proposals must demonstrate the programs would result in significant cost savings to consumers without adding risk of exposure to unsafe or ineffective drugs," he noted.

However, Florida and other states still face hurdles before cheaper drugs can start shipping across the border. The Florida program will need to submit separate requests to the FDA for each prescription drug it wants to import, showing that it can maintain the integrity of the supply chain. The state must show that the drugs brought in from Canada are as effective as U.S.-made medications, and that FDA-approved labels will be added to the medications before they are made available to patients.

The FDA approval is also expected to draw legal challenges from drugmakers, most likely by the lobbying group Pharmaceutical Research and Manufacturers of America (PhRMA). The group has sued over previous efforts to import cheaper drugs from other countries. "We are deeply concerned with the FDA's reckless decision to approve Florida's state importation plan. Ensuring patients have access to needed medicines is critical, but the importation of unapproved medicines, whether from Canada or elsewhere in the world, poses a serious danger to public health," PhRMA president and CEO Stephen Ubl said in a statement Friday. "Politicians need to stop getting between Americans and their health care. PhRMA is considering all options for preventing this policy from harming patients."

In addition, Canada has expressed reservations about its drug supply being co-opted by the United States. "Canada's drug supply is too small to meet the demands of both American and Canadian consumers," Maryse Durette, a spokeswoman for Health Canada, told The New York Times. "Bulk importation will not provide an effective solution to the problem of high drug prices in the U.S."

The New York Times Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-06 06:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords